Zynex Total Assets 2006-2019 | ZYXI
Zynex total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Zynex Annual Total Assets (Millions of US $) |
|
|---|---|
| 2018 | $16 |
| 2017 | $9 |
| 2016 | $4 |
| 2015 | $4 |
| 2014 | $7 |
| 2013 | $17 |
| 2012 | $26 |
| 2011 | $22 |
| 2010 | $16 |
| 2009 | $12 |
| 2008 | $11 |
| 2007 | $7 |
| 2006 | $3 |
| 2005 | $1 |
| Zynex Quarterly Total Assets (Millions of US $) |
|
|---|---|
| Q2 2019 | $22 |
| Q1 2019 | $19 |
| Q4 2018 | $19 |
| Q3 2018 | $13 |
| Q2 2018 | $11 |
| Q1 2018 | $9 |
| Q4 2017 | $9 |
| Q3 2017 | $6 |
| Q2 2017 | $4 |
| Q1 2017 | $4 |
| Q4 2016 | $4 |
| Q3 2016 | $5 |
| Q2 2016 | $4 |
| Q1 2016 | $4 |
| Q4 2015 | $4 |
| Q3 2015 | $5 |
| Q2 2015 | $5 |
| Q1 2015 | $6 |
| Q4 2014 | $7 |
| Q3 2014 | $10 |
| Q2 2014 | $11 |
| Q1 2014 | $16 |
| Q4 2013 | $17 |
| Q3 2013 | $23 |
| Q2 2013 | $24 |
| Q1 2013 | $25 |
| Q4 2012 | $26 |
| Q3 2012 | $26 |
| Q2 2012 | $25 |
| Q1 2012 | $24 |
| Q4 2011 | $22 |
| Q3 2011 | $21 |
| Q2 2011 | $19 |
| Q1 2011 | $17 |
| Q4 2010 | $16 |
| Q3 2010 | $15 |
| Q2 2010 | $13 |
| Q1 2010 | $14 |
| Q4 2009 | $12 |
| Q3 2009 | $12 |
| Q2 2009 | $12 |
| Q1 2009 | $12 |
| Q4 2008 | $11 |
| Q3 2008 | $14 |
| Q2 2008 | $11 |
| Q1 2008 | $9 |
| Q4 2007 | $7 |
| Q3 2007 | $5 |
| Q2 2007 | $4 |
| Q1 2007 | $3 |
| Q4 2006 | $3 |
| Q3 2006 | $2 |
| Q2 2006 | $2 |
| Q1 2006 | $2 |
| Q4 2005 | $1 |
| Q3 2005 | $1 |
| Q2 2005 | $1 |
| Q1 2005 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.384B | $0.032B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $145.155B | 20.38 |
| Abbott Laboratories (ABT) | United States | $144.891B | 27.24 |
| Stryker (SYK) | United States | $80.414B | 27.81 |
| Boston Scientific (BSX) | United States | $53.574B | 25.99 |
| Baxter (BAX) | United States | $44.796B | 27.16 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $32.784B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.311B | 18.12 |
| Coloplast (CLPBY) | Denmark | $25.596B | 40.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.166B | 0.00 |
| Terumo (TRUMY) | Japan | $23.897B | 29.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.556B | 0.00 |
| ResMed (RMD) | United States | $18.755B | 35.74 |
| Sunny Optical Technology (SNPTF) | China | $16.014B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.968B | 53.44 |
| Insulet (PODD) | United States | $9.367B | 555.07 |
| Perrigo (PRGO) | Ireland | $7.321B | 13.49 |
| Canopy Growth (CGC) | Canada | $6.992B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.758B | 20.15 |
| Haemonetics (HAE) | United States | $6.423B | 48.47 |
| William Demant Holdings (WILYY) | Denmark | $5.988B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.322B | 27.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $3.868B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.717B | 0.00 |
| Neogen (NEOG) | United States | $3.401B | 56.90 |
| NuVasive (NUVA) | United States | $3.312B | 26.40 |
| ICU Medical (ICUI) | United States | $3.149B | 20.43 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.522B | 0.00 |
| Quidel (QDEL) | United States | $2.431B | 24.14 |
| Agios Pharmaceuticals (AGIO) | United States | $1.998B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.919B | 41.42 |
| Cardiovascular Systems (CSII) | United States | $1.617B | 0.00 |
| Aphria (APHA) | $1.368B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.117B | 25.74 |
| AtriCure (ATRC) | United States | $1.022B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.885B | 14.39 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.847B | 21.60 |
| NanoString Technologies (NSTG) | United States | $0.779B | 0.00 |
| PetIQ (PETQ) | United States | $0.778B | 18.37 |
| Omeros (OMER) | United States | $0.764B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.742B | 19.50 |
| LeMaitre Vascular (LMAT) | United States | $0.670B | 39.72 |
| Cerus (CERS) | United States | $0.633B | 0.00 |
| Surmodics (SRDX) | United States | $0.607B | 115.31 |
| MacroGenics (MGNX) | United States | $0.562B | 0.00 |
| Quanterix (QTRX) | United States | $0.554B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.510B | 23.60 |
| TG Therapeutics (TGTX) | United States | $0.507B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.423B | 13.21 |
| Owens & Minor (OMI) | United States | $0.406B | 12.17 |
| Utah Medical Products (UTMD) | United States | $0.342B | 25.05 |
| BioLife Solutions (BLFS) | United States | $0.329B | 101.06 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.321B | 0.00 |
| United Health Products (UEEC) | United States | $0.242B | 0.00 |
| Bovie Medical (APYX) | United States | $0.223B | 0.00 |
| Vapotherm (VAPO) | United States | $0.179B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.153B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.148B | 0.00 |
| Female Health (VERU) | United States | $0.137B | 0.00 |
| Fonar (FONR) | United States | $0.131B | 9.16 |
| InfuSystems Holdings (INFU) | United States | $0.129B | 0.00 |
| Liberty Health Sciences (LHSIF) | $0.101B | 0.00 | |
| Chembio Diagnostics (CEMI) | United States | $0.096B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.086B | 20.46 |
| Nephros (NEPH) | United States | $0.077B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.063B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.059B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Surface Oncology (SURF) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.019B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.011B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
